|
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS CALLIBUR FLOW CYTOMETER W/SORTING OPTION; COUNTER, DIFFERENTIAL CELL
|
Back to Search Results |
|
| Model Number |
342976 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
06/08/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medical device expiration date: na.(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that there were erroneous results on patient samples with a bd facs callibur¿ flow cytometer w/sorting option.The following information was provided by the initial reporter, translated from (b)(6) to english: additionally, on 2020-06-11 the fse provided the following additional information: customer conducted a repeat/different test to confirm the results, the problem remains.There was no impact to patient samples and no physical harm/injury due to the issue.No incorrect results been obtained or used.No delay or altercation of treatment due to this problem.
|
| |
|
Additional Manufacturer Narrative
|
|
H.6.Investigation summary: scope of issue: the scope of issue is only limited to part # 342976 and serial # (b)(6).Problem statement: customer reported complaint on a facscalibur 4 color w/sorting ivd - 342976 where cd8 and cd19 are not divided into groups.Manufacturing defect trend: there are zero qns (quality notifications) related to the reported issue.Date range from 08jun2019 to date 08jun2020.Complaint trend: this is the only complaint, # (b)(4), related to this issue of cd8 and cd19 are not divided into groups.Date range from 08jun2019 to date 08jun2020.Manufacturing device history record (dhr) review: review of dhr part # 342976 serial # (b)(6) , file # (b)(4), was reviewed.The instrument met all the manufacturing specifications prior to release.Investigation result / analysis: the investigation was performed and based on the review of the complaint trend, defect trend, dhr, and risk analysis, the root cause of why the cd8 and cd19 antibodies in the data were not divided, or distinctive, was due to a loose laser.This was confirmed by the fse (field service engineer) after evaluating the issue.The fse had repositioned the laser, calibrated the instrument, and brought the instrument to normal operation.To verify that there was an issue with their results, the customer repeated a different test to confirm the results, but the problem still remained.A copy of the data and report were requested per wfi-investigation task 1647756, but the customer refused to provide it.Although this instrument was used for clinical use there was no impact to patient samples and no physical harm/injury due to the issue.No incorrect results were obtained or used nor was there a delay or altercation of treatment due to this problem.After the repair, the instrument was calibrated, tested and functioning as expected.While risk document 342973ra, rev #03, bd facscalibur product family risk analysis rates the severity of the hazard in this investigation a 3 or (moderate s3), there was no significant impact to patient health or safety.H3 other text : see h.10.
|
| |
|
Event or Problem Description
|
|
It was reported that there were erroneous results on patient samples with a bd facs callibur¿ flow cytometer w/sorting option.The following information was provided by the initial reporter, translated from japanese to english: facscalibur instruments cd8 and cd19 (antibody kits) are not divided into groups.2.Placement: cell room, clinical use.Additionally, on 2020-06-11 the fse provided the following additional information: customer conducted a repeat/different test to confirm the results, the problem remains.There was no impact to patient samples and no physical harm/injury due to the issue.No incorrect results been obtained or used.No delay or altercation of treatment due to this problem.
|
| |
|
Search Alerts/Recalls
|
|
|